We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $22.2B
1-Year Est. Return 58.34%
This Fund
S&P 500
This Quarter Est. Return
+31.13%
1 Year Est. Return
+58.34%
3 Year Est. Return
+153.02%
5 Year Est. Return
+199.78%
10 Year Est. Return
+811.75%
AUM
$22.2B
AUM Growth
+$2.96B
Cap. Flow
-$534M
Cap. Flow %
-2.4%
Top 10 Hldgs %
32.73%
Holding
727
New
37
Increased
291
Reduced
287
Closed
50

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$110M
2
ENTG icon
Entegris
ENTG
+$53.1M
3
HLT icon
Hilton Worldwide
HLT
+$45.7M
4
ISRG icon
Intuitive Surgical
ISRG
+$44.3M
5
WDC icon
Western Digital
WDC
+$41.5M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$68.2M
2
JNJ icon
Johnson & Johnson
JNJ
+$67.3M
3
MSFT icon
Microsoft
MSFT
+$64.1M
4
GILD icon
Gilead Sciences
GILD
+$63.1M
5
ON icon
ON Semiconductor
ON
+$62.5M

Sector Composition

Rank Sector Weight
1 Technology 38.31%
2 Healthcare 24.36%
3 Financials 9.42%
4 Communication Services 7.08%
5 Consumer Discretionary 6.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VERA icon
201
Vera Therapeutics
VERA
$2.59B
$20.1M 0.09%
468,099
-7,236
-2% -$270K
DNTH icon
202
Dianthus Therapeutics
DNTH
$6.05B
$19.9M 0.09%
204,214
-9,308
-4% -$813K
DECK icon
203
Deckers Outdoor
DECK
$11.7B
$19.8M 0.09%
199,600
+81,313
+69% +$8.56M
TRGP icon
204
Targa Resources
TRGP
$62.2B
$19.4M 0.09%
72,407
-86,368
-54% -$22.2M
CHE icon
205
Chemed
CHE
$6.79B
$19.3M 0.09%
41,398
-1,844
-4% -$775K
VZ icon
206
Verizon
VZ
$208B
$19.3M 0.09%
455,170
-64,944
-12% -$3.05M
ABT icon
207
Abbott
ABT
$187B
$19.1M 0.09%
211,167
-413,271
-66% -$37.7M
BABA icon
208
Alibaba
BABA
$281B
$19M 0.09%
198,513
-366,305
-65% -$45.9M
OC icon
209
Owens Corning
OC
$11B
$18.9M 0.09%
118,952
+43,290
+57% +$5.26M
WPC icon
210
W.P. Carey
WPC
$16B
$18.9M 0.08%
264,066
-273,121
-51% -$20M
TEVA icon
211
Teva Pharmaceuticals
TEVA
$42.4B
$18.6M 0.08%
550,523
+82,961
+18% +$2.76M
INCY icon
212
Incyte
INCY
$25.7B
$18.4M 0.08%
162,854
-179,188
-52% -$17.8M
LNG icon
213
Cheniere Energy
LNG
$60.3B
$18.3M 0.08%
76,549
-15,384
-17% -$3.83M
IDXX icon
214
Idexx Laboratories
IDXX
$42.2B
$18.2M 0.08%
34,518
-29,497
-46% -$16.5M
CMPS
215
Compass Pathways
CMPS
$1.84B
$18M 0.08%
+1,274,278
New +$12.9M
TRVI icon
216
Trevi Therapeutics
TRVI
$2.46B
$18M 0.08%
966,219
+192,599
+25% +$2.8M
CLDX icon
217
Celldex Therapeutics
CLDX
$3.12B
$17.9M 0.08%
481,125
+202,237
+73% +$6.53M
APD icon
218
Air Products & Chemicals
APD
$67.1B
$17.9M 0.08%
61,054
+20,038
+49% +$5.83M
APP icon
219
Applovin
APP
$107B
$17.7M 0.08%
34,436
-44,123
-56% -$21.3M
MELI icon
220
Mercado Libre
MELI
$100B
$17.7M 0.08%
10,437
-8,975
-46% -$15.3M
MGA icon
221
Magna International
MGA
$18.4B
$17.5M 0.08%
266,907
-30,360
-10% -$1.9M
HOOD icon
222
Robinhood
HOOD
$110B
$16.9M 0.08%
168,854
+100,629
+147% +$8.42M
CIEN icon
223
Ciena
CIEN
$45.5B
$16.9M 0.08%
34,468
+23,212
+206% +$11.8M
NEM icon
224
Newmont
NEM
$135B
$16M 0.07%
171,507
+3,370
+2% +$367K
ATAI icon
225
AtaiBeckley Inc
ATAI
$2.74B
$16M 0.07%
3,039,399
-46,980
-2% -$198K
7 8
9
10 11

Similar funds

DCP
Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
TAF
Tredje AP-fonden Se-111 91 Stockholm, Sweden $22.1B AUM 41.68% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $22.1B AUM 45.54% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $22.3B AUM 36.19% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $22.5B AUM 50.37% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Candriam SCA's Q2 2026 Portfolio in Review

As of Q2 2026, Candriam SCA held 727 positions worth $22.2B, up 15% from $19.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Candriam SCA's Q2 2026 filing shows 37 new, 291 increased, 287 reduced and 50 closed positions. Its largest new stake was BBVA Argentina: 1,335,000 shares worth $26.2M. The largest sale was Micron Technology, an estimated $68.2M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2026 buy was BBVA Argentina: 1,335,000 shares worth $26.2M.
  • Candriam SCA added most to Broadcom in Q2 2026, an estimated $110M increase.
  • Candriam SCA's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $68.2M.
  • Candriam SCA fully exited Ascendis Pharma A/S in Q2 2026, selling an estimated $52.7M.
  • Candriam SCA's ten largest holdings make up 33% of its $22.2B portfolio in Q2 2026.
  • Candriam SCA opened 37 new positions and closed 50 in Q2 2026.
  • Candriam SCA's portfolio value rose 15% quarter-over-quarter to $22.2B.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.